No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder worldwide, reaching prevalence up to 90 % in obese patients with type 2 diabetes (T2D), and representing an independent risk factor for cardiovascular mortality. Furthermore, the coexistence of T2D and NAFLD le...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Med
Main Authors: Barchetta, Ilaria, Del Ben, Maria, Angelico, Francesco, Di Martino, Michele, Fraioli, Antonio, La Torre, Giuseppe, Saulle, Rosella, Perri, Ludovica, Morini, Sergio, Tiberti, Claudio, Bertoccini, Laura, Cimini, Flavia Agata, Panimolle, Francesca, Catalano, Carlo, Baroni, Marco Giorgio, Cavallo, Maria Gisella
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4926287/
https://ncbi.nlm.nih.gov/pubmed/27353492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0638-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares